Commission Implementing Regulation (EU) No 1191/2012 of 12 December 2012 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance sodium salicylate Text with EEA relevance

• CELEX: Implementing Regulation (EU) No 1191/2012
• Articles: 3

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

The entry corresponding to sodium salicylate in Table 1 of the Annex to Regulation (EU) No 37/2010 is replaced by the following:

Pharmacologically active Substance

Marker residue

Animal Species

MRL

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic Classification

‘Sodium salicylate

NOT APPLICABLE

Bovine, porcine

No MRL required

NOT APPLICABLE

For oral use.

Not for use in animals from which milk is produced for human consumption.

NO ENTRY

All food-producing species except fin fish

No MRL required

NOT APPLICABLE

For topical use only.

Salicylic acid

Turkey

400  μg/kg

Muscle

Not for use in animals producing eggs for human consumption.

Anti-inflammatory agents/Non-steroidal anti-inflammatory agents’

2 500  μg/kg

Skin and fat in natural proportions

200  μg/kg

Liver

150  μg/kg

Kidney